Vertex Pharmaceuticals 1 article

Vertex Pharmaceuticals brings cystic fibrosis therapeutics and small molecule correction of protein function into the same corporate research profile, characteristic of a biopharmaceutical company focused on genetically defined diseases. Beyond its core focus, Vertex Pharmaceuticals incorporates genetic disease drug development, sickle cell gene-edited therapy collaboration and type 1 diabetes cell replacement therapy, which together define the surrounding therapeutic context. GenoMethods separates the corporate identity of Vertex Pharmaceuticals from its drug-level entities; non-opioid pain therapeutics remains useful for company-level matching.